Is China's drug industry really better than India's?

Bruce Einhorn

Sorry to pile on, but there’s another report out questioning the ability of India to compete against China. Bain & Co. has released a survey of pharmaceutical executives that concludes that, despite the growth of India’s pharma industry and the aggressive moves by Indian drugmakers like Dr. Reddy’s and Ranbaxy to come up with products that can compete against the best of the West’s Big Pharma, China is a better place than India to make low-cost drugs. “The results released in New Delhi, reveals that nearly 90 percent of pharmaceutical executives considered China a better choice than India for low-cost drug manufacturing,” according to a report here in Silicon India. Here’s how the Hindustan Times headlines a story on the same report: “China outshines India as pharma base: Report.”

To continue reading this article you must be a Bloomberg Professional Service Subscriber.